Clinical Trials Logo
  1. Home
  2. Healthy
  3. NCT02198560
  4. Details
NCT02198560 Clinical Trial

RS-3000 Lite Agreement Study

Healthy Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02198560
Other study ID # NRL-1
Secondary ID
Status Completed
Phase N/A
First received July 17, 2014
Last updated September 9, 2014
Start date August 2014

Study information
Verified date September 2014
Source Nidek Co. LTD.
Contact n/a
Is FDA regulated No
Health authority Japan: Pharmaceuticals and Medical Devices Agency
Study type Observational

Clinical Trial Summary

The primary objectives of the study are to assess the agreement between the two different scan mode of the RS-3000 Lite.

Recruitment information / eligibility
Status Completed
Enrollment 30
Est. completion date
Est. primary completion date August 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Subjects who do not have pathology in both eyes

Exclusion Criteria:

Subjects who have any of the following conditions:

- Diabetes mellitus (DM) and/or diabetic retinopathy

- Uncontrolled Hypertension (HT)

- Cerebral infarction, cerebral hemorrhage, cranial nerve neoplasm and other central nervous system diseases affecting vision

- Cardiac, hepatic, renal and hematologic diseases

- A current condition requiring systemic administration of steroid

- A history of, or currently receiving, anticancer therapy

- Epileptic seizures which are optically induced

- Dementia

Note: Additional criteria may apply

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Device:
• RS-3000 Lite

Locations
Country Name City State
Japan Nabeta Ganaka Iin Okazaki Aichi

Sponsors (1)
Lead Sponsor Collaborator
Nidek Co. LTD.

Country where clinical trial is conducted

Japan, 

Outcome
Type Measure Description Time frame Safety issue
Primary Retinal thickness and Optic Disc Analysis Time frame is the maximum duration of hospital stay. 3 hours No
Secondary Number of participants with adverse events 1day Yes
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1